Immunoinformatics and epitope prediction in the age of genomic medicine

Genome Medicine

Volumn 7, Issue 1, 2015, Pages

  Backert, Linus ^a   Kohlbacher, Oliver ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MAX PLANCK INSTITUTE FOR DEVELOPMENTAL BIOLOGY   (Germany)

Author keywords

Bioinformatics; HLA; Immunoinformatics; Machine learning; Next generation sequencing; Personalized medicine; Vaccine design

Indexed keywords

EPITOPE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA ANTIGEN;

ALLELE; ANTIGEN PRESENTATION; BIOINFORMATICS; EXOME; GENE SEQUENCE; GENOMICS; HLA SYSTEM; HLA TYPING; IMMUNOINFORMATICS; MACHINE LEARNING; NEXT GENERATION SEQUENCING; PREDICTION; PRIORITY JOURNAL; REVIEW; RNA SEQUENCE; BIOLOGY; EPITOPE MAPPING; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; IMMUNOLOGY; NEOPLASMS; PERSONALIZED MEDICINE; PROCEDURES;

COMPUTATIONAL BIOLOGY; EPITOPE MAPPING; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HLA ANTIGENS; HUMANS; NEOPLASMS; PRECISION MEDICINE;

EID: 84947716406     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/s13073-015-0245-0     Document Type: Review

References (91)

1. Robinson J, Halliwell JA, Hayhurst JD, Flicek P, Parham P, Marsh SG. The IPD and IMGT/HLA database: allele variant databases. Nucleic Acids Res. 2015;43(Database issue):423-31. doi: 10.1093/nar/gku1161.
2. Toussaint NC, Maman Y, Kohlbacher O, Louzoun Y. Universal peptide vaccines - optimal peptide vaccine design based on viral sequence conservation. Vaccine. 2011;29:8745-53. doi: 10.1016/j.vaccine.2011.07.132.
3. Britten CM, Singh-Jasuja H, Flamion B, Hoos A, Huber C, Kallen KJ, et al. The regulatory landscape for actively personalized cancer immunotherapies. Nat Biotechnol. 2013;31:880-2. doi: 10.1038/nbt.2708.
4. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature. 1991;351:290-6. doi: 10.1038/351290a0.
5. McCullough AK, Scharer O, Verdine GL, Lloyd RS. Structural determinants for specific recognition by T4 endonuclease V. J Biol Chem. 1996;271:32147-52. doi: 10.1074/jbc.271.50.32147. 0-387-31073-8.
6. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25:3389-402.
7. Dönnes P, Elofsson A. Prediction of MHC class I binding peptides, using SVMHC. BMC Bioinformatics. 2002;3:25. doi: 10.1186/1471-2105-3-25.
8. Wan J, Liu W, Xu Q, Ren Y, Flower DR, Li T. SVRMHC prediction server for MHC-binding peptides. BMC Bioinformatics. 2006;7:463. doi: 10.1186/1471-2105-7-463.
9. Noguchi H, Kato R, Hanai T, Matsubara Y, Honda H, Brusic V, et al. Hidden Markov model-based prediction of antigenic peptides that interact with MHC class II molecules. J Biosci Bioeng. 2002;94:264-70. doi: 10.1016/S1389-1723(02)80160-8.
10. Lundegaard C, Lund O, Nielsen M. Prediction of epitopes using neural network based methods. J Immunol Methods. 2011;374:26-34. doi: 10.1016/j.jim.2010.10.011.
11. Fawcett T. An introduction to ROC analysis. Pattern Recognition Lett. 2006;7:861-74. doi: 10.1016/j.patrec.2005.10.010.
12. Matthews BW. Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochim Biophys Acta. 1975;405:442-51. doi: 10.1016/0005-2795(75)90109-9.
13. Toussaint NC, Kohlbacher O. Towards in silico design of epitope-based vaccines. Expert Opin Drug Discov. 2009;4:1047-60. doi: 10.1517/17460440903242283.
14. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics. 1999;50:213-9. doi: 10.1007/s002510050595.
15. Vita R, Overton JA, Greenbaum JA, Ponomarenko J, Clark JD, Cantrell JR, et al. The immune epitope database (IEDB) 3.0. Nucleic Acids Res. 2015;43(Database issue):405-12. doi: 10.1093/nar/gku938.
16. Lata S, Bhasin M, Raghava GPS. MHCBN 4.0: A database of MHC/TAP binding peptides and T-cell epitopes. BMC Res Notes. 2011;2:61. doi: 10.1186/1756-0500-2-61.
17. Toseland CP, Clayton DJ, McSparron H, Hemsley SL, Blythe MJ, Paine K, et al. AntiJen: a quantitative immunology database integrating functional, thermodynamic, kinetic, biophysical, and cellular data. Immunome Res. 2005;1:4. doi: 10.1186/1745-7580-1-4.
18. Lefranc M-P, Giudicelli V, Ginestoux C, Jabado-Michaloud J, Folch G, Bellahcene F, et al. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 2009;37(Database issue):1006-12. doi: 10.1093/nar/gkn838.
19. Szolek A, Schubert B, Mohr C, Sturm M, Feldhahn M, Kohlbacher O, et al. OptiType: precision HLA typing from next-generation sequencing data. Bioinformatics. 2014;30:3310-6. doi: 10.1093/bioinformatics/btu548.
20. Shukla SA, Rooney MS, Rajasagi M, Tiao G, Dixon PM, Lawrence MS, et al. Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes. Nat Biotechnol. 2015. doi: 10.1038/nbt.3344.
21. Zhang GL, Lin HH, Keskin DB, Reinherz EL, Brusic V. Dana-Farber repository for machine learning in immunology. J Immunol Methods. 2011;374:18-25. doi: 10.1016/j.jim.2011.07.007.
22. Erlich H. HLA DNA, typing: past, present, and future. Tissue Antigens. 2012;80:1-11. doi: 10.1111/j.1399-0039.2012.01881.x.
23. Zhang J, Baran J, Cros A, Guberman JM, Haider S, Hsu J, et al. International Cancer Genome Consortium Data Portal - a one-stop shop for cancer genomics data. Database. 2011. doi: 10.1093/database/bar026.
24. 1000 Genomes Project Consortium, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56-65. doi: 10.1038/nature11632.
25. Liu C, Yang X, Duffy B, Mohanakumar T, Mitra RD, Zody MC, et al. ATHLATES: accurate typing of human leukocyte antigen through exome sequencing. Nucleic Acids Res. 2013;41:142. doi: 10.1093/nar/gkt481.
26. Boegel S, Lower M, Schafer M, Bukur T, de Graaf J, Boisguérin V, et al. HLA typing from RNA-Seq sequence reads. Genome Med. 2012;12:102. doi: 10.1186/gm403.
27. Reche PA, Glutting J-P, Reinherz EL. Prediction of MHC class I binding peptides using profile motifs. Human Immunol. 2002;63:701-9.
28. Parker KC, Bednarek MA, Coligan JE. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol. 1994;152:163-75.
29. Lundegaard C, Lamberth K, Harndahl M, Buus S, Lund O. NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11. Nucleic Acids Res. 2008;36(Web Server issue):509-12. doi: 10.1093/nar/gkn202.
30. Peters B, Tong W, Sidney J, Sette A, Weng Z. Examining the independent binding assumption for binding of peptide epitopes to MHC-I molecules. Bioinformatics. 2003;19:1765-72. doi: 10.1093/bioinformatics/btg247.
31. Yu K, Petrovsky N, Schonbach C, Koh JYL, Brusic V. Methods for prediction of peptide binding to MHC molecules: a comparative study. Mol Med. 2002;8:137-48.
32. Gulukota K, Sidney J, Sette A, DeLisi C. Two complementary methods for predicting peptides binding major histocompatibility complex molecules. J Mol Biol. 1997;267:1258-67. doi: 10.1006/jmbi.1997.0937.
33. Peters B, Bui H-H, Frankild S, Nielson M, Lundegaard C, Kostem E, et al. A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput Biol. 2006;2:e65. doi: 10.1371/journal.pcbi.0020065.
34. Lin HH, Ray S, Tongchusak S, Reinherz EL, Brusic V. Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research. BMC Immunol. 2008;9:8. doi: 10.1186/1471-2172-9-8.
35. 2nd Machine Learning Competition in Immunology 2012. http://bio.dfci.harvard.edu/DFRMLI/HTML/natural.php. Accessed 2015-08-31.
36. Lundegaard C, Lund O, Kesmir C, Brunak S, Nielsen M. Modeling the adaptive immune system: predictions and simulations. Bioinformatics. 2007;23:3265-75. doi: 10.1093/bioinformatics/btm471.
37. Trolle T, Metushi IG, Greenbaum JA, Kim Y, Sidney J, Lund O, et al. Automated benchmarking of peptide-MHC class I binding predictions. Bioinformatics. 2015;31:2174-81. doi: 10.1093/bioinformatics/btv123.
38. Zhang H, Lundegaard C, Nielsen M. Pan-specific MHC class I predictors: a benchmark of HLA class I pan-specific prediction methods. Bioinformatics. 2009;25:83-9. doi: 10.1093/bioinformatics/btn579.
39. Zhang GL, Khan AM, Srinivasan KN, August JT, Brusic V. MULTIPRED: a computational system for prediction of promiscuous HLA binding peptides. Nucleic Acids Res. 2005;33(Web Server issue):172-9. doi: 10.1093/nar/gki452.
40. Nielsen M, Lundegaard C, Blicher T, Lamberth K, Harndahl M, Justesen S, et al. NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS One. 2007;2:e796. doi: 10.1371/journal.pone.0000796.
41. Zhang H, Lund O, Nielsen M. The PickPocket method for predicting binding specificities for receptors based on receptor pocket similarities: application to MHC-peptide binding. Bioinformatics. 2009;25:1293-9. doi: 10.1093/bioinformatics/btp137.
42. Zhang L, Chen Y, Wong H-S, Zhou S, Mamitsuka H, Zhu S. TEPITOPEpan: extending TEPITOPE for peptide binding prediction covering over 700 HLA-DR molecules. PLoS One. 2012;7:e30483. doi: 10.1371/journal.pone.0030483.
43. Jojic N, Reyes-Gomez M, Heckerman D, Kadie C, Schueler-Furman O. Learning MHC I-peptide binding. Bioinformatics. 2006;22:227-35. doi: 10.1093/bioinformatics/btl255.
44. Toussaint NC, Feldhahn M, Ziehm M, Stevanovic S, Kohlbacher O. T-cell epitope prediction based on self-tolerance. In: Proceedings of the 2nd ACM Conference on Bioinformatics, Computational Biology and Biomedicine - BCB '11. New York: ACM Press; 2011. p. 584. doi: 10.1145/2147805.2147905.
45. Jacob L, Vert J-P. Efficient peptide-MHC-I binding prediction for alleles with few known binders. Bioinformatics. 2008;24:358-66. doi: 10.1093/bioinformatics/btm611.
46. Harndahl M, Rasmussen M, Roder G, Dalgaard Pedersen I, Sørensen M, Nielsen M, et al. Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity. Eur J Immunol. 2012;42:1405-16. doi: 10.1002/eji.201141774.
47. Jørgensen KW, Rasmussen M, Buus S, Nielsen M. NetMHCstab - predicting stability of peptide-MHC-I complexes; impacts for cytotoxic T lymphocyte epitope discovery. Immunology. 2014;141:18-26. doi: 10.1111/imm.12160.
48. Nielsen M, Lundegaard C, Lund O. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics. 2007;8:238. doi: 10.1186/1471-2105-8-238.
49. Nielsen M, Lund O. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinformatics. 2009;10:296. doi: 10.1186/1471-2105-10-296.
50. Singh H, Raghava GP. ProPred: prediction of HLA-DR binding sites. Bioinformatics. 2001;17:1236-7. doi: 10.1093/bioinformatics/17.12.1236.
51. Bian H, Hammer J. Discovery of promiscuous HLA-II-restricted T cell epitopes with TEPITOPE. Methods. 2004;34:468-75. doi: 10.1016/j.ymeth.2004.06.002.
52. Xu Y, Luo C, Qian M, Huang X, Zhu S. MHC2MIL: a novel multiple instance learning based method for MHC-II peptide binding prediction by considering peptide flanking region and residue positions. BMC Genomics. 2014;15(Suppl 9). doi: 10.1186/1471-2164-15-S9-S9.
53. Gowthaman U, Agrewala JN. In silico tools for predicting peptides binding to HLA-class II molecules: more confusion than conclusion. J Proteome Res. 2008;7:154-63. doi: 10.1021/pr070527b.
54. Wang P, Sidney J, Dow C, Mothe B, Sette A, Peters B. A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput Biol. 2008;4:e1000048. doi: 10.1371/journal.pcbi.1000048.
55. Pfeifer N, Kohlbacher O. Multiple instance learning allows MHC class II epitope predictions across alleles. In: Algorithms in Bioinformatics; Springer, Berlin, Heidelberg; 2008. p. 210-21. http://link.springer.com/10.1007/978-3-540-87361-718.
56. Karosiene E, Rasmussen M, Blicher T, Lund O, Buus S, Nielsen M. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ. Immunogenetics. 2013;65:711-24. doi: 10.1007/s00251-013-0720-y.
57. +)-cell responses to vaccinia virus. Nat Biotechnol. 2006;24:817-9. doi: 10.1038/nbt1215.
58. Karosiene E, Lundegaard C, Lund O, Nielsen M. NetMHCcons: a consensus method for the major histocompatibility complex class I predictions. Immunogenetics. 2012;64:177-86. doi: 10.1007/s00251-011-0579-8.
59. Calis JJA, Reinink P, Keller C, Kloetzel PM, Kesmir C. Role of peptide processing predictions in T cell epitope identification: contribution of different prediction programs. Immunogenetics. 2015;67:85-93. doi: 10.1007/s00251-014-0815-0.
60. Nielsen M, Lundegaard C, Lund O, Kesmir C. The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage. Immunogenetics. 2005;57:33-41. doi: 10.1007/s00251-005-0781-7.
61. Dönnes P, Kohlbacher O. Integrated modeling of the major events in the MHC class I antigen processing pathway. Protein Sci. 2005;4:2132-40. doi: 10.1110/ps.051352405.
62. Holzhutter HG, Frommel C, Kloetzel PM. A theoretical approach towards the identification of cleavage-determining amino acid motifs of the 20 S proteasome. J Mol Biol. 1999;286:1251-65. doi: 10.1006/jmbi.1998.2530.
63. Bhasin M, Raghava GPS. Pcleavage: an SVM based method for prediction of constitutive proteasome and immunoproteasome cleavage sites in antigenic sequences. Nucleic Acids Res. 2005;33(Web Server issue):202-7. doi: 10.1093/nar/gki587.
64. Kuttler C, Nussbaum AK, Dick TP, Rammensee HG, Schild H, Hadeler KP. An algorithm for the prediction of proteasomal cleavages. J Mol Biol. 2000;298:417-29. doi: 10.1006/jmbi.2000.3683.
65. Lucchiari-Hartz M, Lindo V, Hitziger N, Gaedicke S, Saveanu L, van Endert PM, et al. Differential proteasomal processing of hydrophobic and hydrophilic protein regions: contribution to cytotoxic T lymphocyte epitope clustering in HIV-1-Nef. Proc Natl Acad Sci U S A. 2003;100:7755-60. doi: 10.1073/pnas.1232228100.
66. Saxova P, Buus S, Brunak S, Kesmir C. Predicting proteasomal cleavage sites: a comparison of available methods. Int Immunol. 2003;15:781-7. doi: 10.1093/intimm/dxg084.
67. Daniel S, Brusic V, Caillat-Zucman S, Petrovsky N, Harrison L, Riganelli D, et al. Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules. J Immunol. 1998;161:617-24.
68. Gubler B, Daniel S, Armandola EA, Hammer J, Caillat-Zucman S, van Endert PM. Substrate selection by transporters associated with antigen processing occurs during peptide binding to TAP. Mol Immunol. 1998;35:427-33. doi: 10.1016/S0161-5890(98)00059-5.
69. Zhang GL, Petrovsky N, Kwoh CK, August JT, Brusic V. PRED(TAP): a system for prediction of peptide binding to the human transporter associated with antigen processing. Immunome Res. 2006;2:3. doi: 10.1186/1745-7580-2-3.
70. Doytchinova IA, Guan P, Flower DR. EpiJen: a server for multistep T cell epitope prediction. BMC Bioinformatics. 2006;7:131. doi: 10.1186/1471-2105-7-131.
71. Larsen MV, Lundegaard C, Lamberth K, Buus S, Lund O, Nielsen M. Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics. 2007;8:424. doi: 10.1186/1471-2105-8-424.
72. Stranzl T, Larsen MV, Lundegaard C, Nielsen M. NetCTLpan: pan-specific MHC class I pathway epitope predictions. Immunogenetics. 2010;62:357-68. doi: 10.1007/s00251-010-0441-4.
73. Brusic V, van Endert P, Zeleznikow J, Daniel S, Hammer J, Petrovsky N. A neural network model approach to the study of human TAP transporter. In Silico Biol. 1999;1:109-21.
74. Tung C-W, Ho S-Y. POPI: predicting immunogenicity of MHC class I binding peptides by mining informative physicochemical properties. Bioinformatics. 2007;23:942-9. doi: 10.1093/bioinformatics/btm061.
75. Tung C-W, Ziehm M, Kamper A, Kohlbacher O, Ho S-Y. POPISK: T-cell reactivity prediction using support vector machines and string kernels. BMC Bioinformatics. 2011;12:446. doi: 10.1186/1471-2105-12-446.
76. Calis JJA, Maybeno M, Greenbaum JA, Weiskopf D, De Silva AD, Sette A, et al. Properties of MHC class I presented peptides that enhance immunogenicity. PLoS Comput Biol. 2013;9:e1003266. doi: 10.1371/journal.pcbi.1003266.
77. Kringelum JV, Nielsen M, Padkjær SB, Lund O. Structural analysis of B-cell epitopes in antibody:protein complexes. Mol Immunol. 2013;53:24-34. doi: 10.1016/j.molimm.2012.06.001. NIHMS150003.
78. Sweredoski MJ, Baldi P. COBEpro: a novel system for predicting continuous B-cell epitopes. Protein Eng Des Sel. 2009;22:113-20. doi: 10.1093/protein/gzn075.
79. El-Manzalawy Y, Dobbs D, Honavar V. Predicting flexible length linear B-cell epitopes. Comput Syst Bioinformatics Conf. 2008;7:121-32. doi: 10.1002/jmr.893.
80. Blythe MJ, Flower DR. Benchmarking B cell epitope prediction: underperformance of existing methods. Protein Sci. 2005;14:246-8. doi: 10.1110/ps.041059505.
81. Yao B, Zheng D, Liang S, Zhang C. Conformational B-cell epitope prediction on antigen protein structures: a review of current algorithms and comparison with common binding site prediction methods. PLoS One. 2013;8:e62249. doi: 10.1371/journal.pone.0062249.
82. Liang S, Zheng D, Standley DM, Yao B, Zacharias M, Zhang C. EPSVR and EPMeta: prediction of antigenic epitopes using support vector regression and multiple server results. BMC Bioinformatics. 2010;11:381. doi: 10.1186/1471-2105-11-381.
83. Kringelum JV, Lundegaard C, Lund O, Nielsen M. Reliable B cell epitope predictions: impacts of method development and improved benchmarking. PLoS Comput Biol. 2012;8:e1002829. doi: 10.1371/journal.pcbi.1002829.
84. Vider-Shalit T, Raffaeli S, Louzoun Y. Virus-epitope vaccine design: informatic matching the HLA-I polymorphism to the virus genome. Mol Immunol. 2007;44:1253-61. doi: 10.1016/j.molimm.2006.06.003.
85. Toussaint NC, Dönnes P, Kohlbacher O. A mathematical framework for the selection of an optimal set of peptides for epitope-based vaccines. PLoS Comput Biol. 2008;4:e1000246. doi: 10.1371/journal.pcbi.1000246.
86. Pappalardo F, Brusic V, Castiglione F, Schonbach C. Computational and bioinformatics techniques for immunology. BioMed Res Int. 2014;2014:263189. doi: 10.1155/2014/263189.
87. Feldhahn M, Dönnes P, Thiel P, Kohlbacher O. FRED - a framework for T-cell epitope detection. Bioinformatics. 2009;25:2758-9. doi: 10.1093/bioinformatics/btp409.
88. Goecks J, Nekrutenko A, Taylor J. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol. 2010;11:86. doi: 10.1186/gb-2010-11-8-r86.
89. Schubert B, Brachvogel H-P, Jurges C, Kohlbacher O. EpiToolKit - a web-based workbench for vaccine design. Bioinformatics. 2015;31:2211-3. doi: 10.1093/bioinformatics/btv116.
90. Andreatta M, Karosiene E, Rasmussen M, Stryhn A, Buus S, Nielsen M. Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification. Immunogenetics. 2015. doi: 10.1007/s00251-015-0873-y.
91. Sette A, Buus S, Appella E, Adorini L, Grey HM. Structural requirements for the interaction between class II MHC molecules and peptide antigens. Immunologic Res. 1990;9:2-7. doi: 10.1007/BF02918474.